Amphastar gained share in this market rapidly, and we expect the company to cede share in short order. Glucagon has two primary markets: retail, in which diabetics carry glucagon emergency kits to ...

The FDA determined that Amphastar Pharmaceuticals' Glucagon for Injection Emergency Kit, 1 mg, a synthetic peptide product, is bioequivalent and therapeutically equivalent to Eli Lilly's ...

The generic glucagon (Amphastar Pharmaceuticals Inc.) is packaged as a 1 mg vial emergency kit. In its approval, the FDA found the generic glucagon to be bioequivalent and therapeutically ...

Baqsimi will give Amphastar a second emergency product for severe hypoglycemia. The company already markets a generic version of injectable glucagon for emergency kits. “The acquisition of ...

Amphastar Pharmaceuticals ... REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with ...

Fresenius Kabi announced the launch of Glucagon Emergency Kit for the treatment of severe hypoglycemic episodes in adult and pediatric patients with diabetes. Fresenius Kabi announced the launch ...

The format is potentially more convenient than traditional glucagon kits from the likes of Fresenius Kabi and Amphastar ... blood glucose don’t carry an emergency kit. Supported by Xeris ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat ...